Publication: 2619

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 16 (21) 5222-5232
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
895  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
Breast    
Pharmas:
 
Grants:
U01 CA114722-01, P30 ES010126, P30 CA42014-19, P50-CA58223-09A1, U01 CA114722, P30 CA91842, P50 CA058223, P30 CA091842, P30 CA042014  
Corr. Author:
 
Authors:
                               
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-159905, CALGB-9344
Phases:
3, N/A
Keywords:
Article